Anti-Müllerian Hormone (AMH) is the most reliable marker for evaluating ovarian reserve and estimating a woman’s reproductive potential. Its determination is key in both fertility studies and reproductive planning.

This analysis provides the approximate number of available ovarian follicles, helping to anticipate ovarian response in assisted reproduction treatments (IVF/ICSI) and to make personalized clinical decisions.

Unlike other hormones, AMH can be measured at any point during the menstrual cycle, making it a practical and precise tool.